Ghanaian neuroscientist's Alzheimer's blood test breakthrough wins global recognition at Millennium Awards

Dr. Thomas Karikari, an associate professor of psychiatry and clinical and translational science at the University of Pittsburgh's School of Medicine, has been recognised as one of the world's leading researchers in neuroscience following his groundbreaking work on Alzheimer's diagnostics. The Ghanaian scientist received the Excellence in Scientific Research award at the Millennium Excellence Awards ceremony in Washington, DC, held under the royal patronage of Otumfuo Osei Tutu II, the Asantehene.

Karikari's achievement marks a watershed moment in global neuroscience research. Over the past several years, he has developed multiple blood-based tests that can detect Alzheimer's disease without invasive procedures such as spinal taps or expensive brain imaging—a breakthrough that promises to democratise diagnosis across the world, particularly in low-resource settings.

From Scepticism to Breakthrough Innovation

When Karikari first posed the question "Why don't we have a good blood test kit for Alzheimer's dementia?" in his laboratory in Sweden, the scientific community was dismissive. Leading companies had invested millions of dollars attempting the same feat without success. Senior figures in the field discouraged him from pursuing what many considered an impossible goal.

"I was told you don't talk about it. Companies have spent millions; they couldn't do it. People have spent years, but they couldn't do it. So, just shut up," he recounted. Undeterred, Karikari embarked on the research as a side project, knowing few believed it would succeed. His determination eventually paid dividends, culminating in the development of several FDA-approved blood tests for Alzheimer's and other dementias.

The scale of his contributions to the field is evident in his academic output: Karikari has authored approximately 300 publications in leading medical journals and holds multiple patents and pending patent applications. Last year, Clarivate recognised him as among the top 1% of scientists worldwide, whilst the prestigious journal Nature named him a Rising Star in Ageing research—an honour awarded to only three investigators globally.

Why This Matters for Ghana and Africa

Karikari's work carries profound significance for Ghana and the broader African continent. For decades, diagnosis of Alzheimer's and other dementias in resource-limited settings has been nearly impossible, leaving millions of elderly Africans without proper medical assessment or care pathways. The availability of simple blood tests promises to change this reality fundamentally.

More importantly, Karikari's personal mission extends beyond international recognition. He has acquired land in Achinakrom near Ejisu in the Ashanti Region—his late mother's hometown—where he plans to establish a dedicated research centre for biomedical research on the African continent. This commitment reflects his determination to ensure that breakthrough innovations benefit his home nation and broader Africa.

"Everything we do must get back to our people," Karikari emphasised, underscoring a philosophy that prioritises accessible healthcare solutions for communities often excluded from cutting-edge medical advances. His vision of bringing world-class neuroscience research infrastructure to Ghana represents a rare opportunity for the country to become a hub for transformative health research on the continent.

FDA Approvals and Future Momentum

During his acceptance speech at the Millennium Excellence Awards, Karikari noted that two new blood tests for Alzheimer's disease have recently received FDA approval, bringing the total number of approved tests developed through his research programme to four within the past two years. This accelerating pace of approvals demonstrates the clinical validity and applicability of his innovations.

As neurodegenerative diseases place increasing burden on healthcare systems globally—including in Ghana—the availability of affordable, non-invasive diagnostic tools will enable earlier detection, better patient management, and improved outcomes for millions. Karikari's work exemplifies how Ghanaian scientists working at the highest international levels can drive innovations with transformative local and global impact.